My expertise and interests are rather broad. I publish in the areas of nanomedicine, autoimmune disease, and neurobiology. I am transitioning into retirement so I no longer run a research lab or take students for training. I am still collaborating with Dr Dmitri Simberg on areas relating to nanomedicine and with Dr Nirmal Banda on areas relating to Rheumatoid Arthritis. I coordinate the Fundamentals of Pharmaceutical Sciences and Seminar in Pharmaceutical Sciences courses for our graduate programs.
Education, Licensure & Certifications
- BS, Massachusetts Institute of Technology (Biology)
- PhD, University of Washington, Seattle (Pharmacology)
Affiliations
- Member, University of Colorado Cancer Center
Research Interest
- Immunology and nanoformulations/drug delivery systems
- Molecular biology immunology and nanotechnology
Publications and Presentations
- Williams-Skipp, C., Raman, T., Valuck, R.J., Watkins, H., Palmer, B.E., and Scheinman, R.I. (2009) Unmasking of a Protective TNFR1 Mediated Signal in the Collagen Arthritis Model. Arthritis Rheum. 60(2):408-18
- Scheinman, RI, Trivedi, R, Vermillion, S, Kompella, U (2011) RGD-Functionalized STAT1 siRNA Nanoparticles Regress Rheumatoid Arthritis in a Mouse Model. Nanomedicine (London) 6(10):1669-1682.
- Mehta, G, Scheinman, RI, Holers, VM, Banda NK. (2015) A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5R1 Antibody and C5 Small Interfering RNA. J. Immunol. 194(11):5446-54
- Vu VP, Gifford GB, Chen F, Benasutti H, Wang G, Groman EV, Scheinman R, Saba L, Moghimi SM, Simberg D. (2019) Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nature Nanotechnology 14(3):260-268.